Rationale for Designing of Antigen-Specific Immune Therapy Including Dendritic Cell-Based Therapy in Patients with Chronic Hepatitis B Virus Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-6018|5|1|75-84

ISSN： 1871-5214

Source： Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol.5, Iss.1, 2006-01, pp. : 75-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bezafibrate therapy reduces serum hepatitis C virus (HCV) RNA titre in patients with chronic HCV infection

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Five reports of reactivation of hepatitis B virus infection in patients who had received cancer chemotherapy or immunosuppressive therapy

By  

Reactions Weekly, Vol. 1, Iss. 1105, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Five reports of reactivation of hepatitis B virus infection in patients who had received cancer chemotherapy or immunosuppressive therapy

By  

Inpharma, Vol. 1, Iss. 1541, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2111-2122

Bentham Science Publishers

Access to resources Recommend Favorite